Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05903391 · ClinicalTrials.gov registry record · NA
Splint Users' Satisfaction and Functional Status With Custom Finger Splints
A NA study of Hypermobility of Interphalangeal Joints and Swan-Neck Deformity, sponsored by Endeavor Health.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 2
- Study locations
NCT05903391: Completed NA study of Hypermobility of Interphalangeal Joints and Swan-Neck Deformity, sponsored by Endeavor Health.
NCT05903391 is a NA study of Hypermobility of Interphalangeal Joints and Swan-Neck Deformity that has completed, run by Endeavor Health. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05903391, a NA study of Hypermobility of Interphalangeal Joints and Swan-Neck Deformity, has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 2
- Study locations
Study Summary
This feasibility and non-randomized comparison study explores the possible benefits of splint design and production by 3D-printing in a clinical setting and looks at splint users' experiences with customizable 3D-printed finger splints compared to conventionally made splints. Fifty participants with a hyperextended finger condition are assigned by researcher to either an interventional group (customizable 3D-printed finger splint) or a control group (conventional thermoplastic finger splint). Participants will wear assigned splint for 1 month. Functional status and satisfaction with splint will be assessed at the end of the 1-month duration in the form of surveys on satisfaction and functional status participants will be asked to complete. The findings will contribute to evidence that customizable 3D-printed finger splints can serve as a feasible, cost-effective option to improve patient satisfaction and functional status. It will further justify the need for the application of 3D-printing in a clinical setting.
Primary Outcome
A modified version of a Self-report questionnaire which measures participants satisfaction with assigned splint device
Conditions Studied
Interventions
- DEVICE 3D-Printed Finger Splints
- DEVICE Conventional Finger Splints
Study Locations (2)
Illinois
- Swedish Hospital Part of NorthShore University HealthSystems - Chicago
- NorthShore University HealthSystem - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2023-11-09 |
| Est. Completion | 2025-02-17 |
| Phase | NA |
What the finished NCT05903391 record still lists
NCT05903391 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Hypermobility of Interphalangeal Joints appearing as the primary indexed condition, and to 2 interventions - of which 3D-Printed Finger Splints is the first listed.
NCT05903391 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05903391 about?
NCT05903391 is a clinical study titled "Splint Users' Satisfaction and Functional Status With Custom Finger Splints". This feasibility and non-randomized comparison study explores the possible benefits of splint design and production by 3D-printing in a clinical setting and looks at splint users' experiences with customizable 3D-printed finger splints compared to conventionally made splints. Fifty participants with...
What is the current status of trial NCT05903391?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2023-11-09. Estimated completion is 2025-02-17.
What conditions does trial NCT05903391 study?
This clinical trial studies the following conditions: Hypermobility of Interphalangeal Joints, Swan-Neck Deformity.
What interventions are being tested in trial NCT05903391?
The interventions under investigation include: 3D-Printed Finger Splints (DEVICE), Conventional Finger Splints (DEVICE).
Who is sponsoring clinical trial NCT05903391?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05903391 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05903391's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI